Natera, Inc.
Jonathan Sheena (Director) sells NTRA shares
AI-generated summary
Director, CO-FOUNDER Jonathan Sheena sold 3,150 shares of Common Stock for an average price of $410.55, with a total value of $1,293,245.61. Following these transactions, the insider directly held 218,164 shares. The sales were made under a Rule 10b5-1 trading plan adopted on December 12, 2025.
Key facts
- Insider
- Jonathan Sheena · Director
Rule 10b5-1 plan · adopted Dec 12, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | S · open-market saleFootnotes F1 | −200 | $406.50 | $81,300.00 | 221,114 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F2 | −962 | $408.26 | $392,744.58 | 220,152 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F3 | −627 | $409.89 | $257,003.04 | 219,525 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F4 | −605 | $411.32 | $248,847.09 | 218,920 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F5 | −211 | $412.20 | $86,974.01 | 218,709 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F6 | −125 | $413.05 | $51,630.95 | 218,584 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F7 | −255 | $415.67 | $105,994.80 | 218,329 | Direct |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F8 | −165 | $416.67 | $68,751.14 | 218,164 | Direct |
Footnotes
- F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $408.00 to $408.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.22 to $410.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $410.91 to $411.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.00 to $412.21 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.00 to $413.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.35 to $416.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.36 to $416.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
More NTRA filings
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.